RSLS
Price
$4.18
Change
-$0.07 (-1.65%)
Updated
Jun 6 closing price
Capitalization
4.33M
SMLR
Price
$32.98
Change
+$0.34 (+1.04%)
Updated
Jun 6 closing price
Capitalization
203.76M
65 days until earnings call
Interact to see
Advertisement

RSLS vs SMLR

Header iconRSLS vs SMLR Comparison
Open Charts RSLS vs SMLRBanner chart's image
ReShape Lifesciences
Price$4.18
Change-$0.07 (-1.65%)
Volume$257.6K
Capitalization4.33M
Semler Scientific
Price$32.98
Change+$0.34 (+1.04%)
Volume$1.02M
Capitalization203.76M
RSLS vs SMLR Comparison Chart
Loading...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RSLS vs. SMLR commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSLS is a StrongBuy and SMLR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (RSLS: $4.18 vs. SMLR: $32.98)
Brand notoriety: RSLS and SMLR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: RSLS: 10% vs. SMLR: 138%
Market capitalization -- RSLS: $4.33M vs. SMLR: $203.76M
RSLS [@Medical Specialties] is valued at $4.33M. SMLR’s [@Medical Specialties] market capitalization is $203.76M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RSLS’s FA Score shows that 0 FA rating(s) are green whileSMLR’s FA Score has 0 green FA rating(s).

  • RSLS’s FA Score: 0 green, 5 red.
  • SMLR’s FA Score: 0 green, 5 red.
According to our system of comparison, SMLR is a better buy in the long-term than RSLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RSLS’s TA Score shows that 4 TA indicator(s) are bullish while SMLR’s TA Score has 5 bullish TA indicator(s).

  • RSLS’s TA Score: 4 bullish, 3 bearish.
  • SMLR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SMLR is a better buy in the short-term than RSLS.

Price Growth

RSLS (@Medical Specialties) experienced а -14.87% price change this week, while SMLR (@Medical Specialties) price change was -17.55% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.46%. For the same industry, the average monthly price growth was +5.98%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

RSLS is expected to report earnings on Apr 04, 2025.

SMLR is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (+2.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMLR($204M) has a higher market cap than RSLS($4.33M). SMLR YTD gains are higher at: -38.926 vs. RSLS (-96.251). SMLR has higher annual earnings (EBITDA): 23.6M vs. RSLS (-36.72M). SMLR has more cash in the bank: 57.2M vs. RSLS (1.45M). SMLR has less debt than RSLS: SMLR (160K) vs RSLS (285K). SMLR has higher revenues than RSLS: SMLR (68.2M) vs RSLS (9.81M).
RSLSSMLRRSLS / SMLR
Capitalization4.33M204M2%
EBITDA-36.72M23.6M-156%
Gain YTD-96.251-38.926247%
P/E RatioN/A11.02-
Revenue9.81M68.2M14%
Total Cash1.45M57.2M3%
Total Debt285K160K178%
FUNDAMENTALS RATINGS
RSLS vs SMLR: Fundamental Ratings
RSLS
SMLR
OUTLOOK RATING
1..100
3561
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9736
PRICE GROWTH RATING
1..100
9863
P/E GROWTH RATING
1..100
10082
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSLS's Valuation (36) in the Medical Specialties industry is in the same range as SMLR (64). This means that RSLS’s stock grew similarly to SMLR’s over the last 12 months.

RSLS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SMLR (100). This means that RSLS’s stock grew similarly to SMLR’s over the last 12 months.

SMLR's SMR Rating (36) in the Medical Specialties industry is somewhat better than the same rating for RSLS (97). This means that SMLR’s stock grew somewhat faster than RSLS’s over the last 12 months.

SMLR's Price Growth Rating (63) in the Medical Specialties industry is somewhat better than the same rating for RSLS (98). This means that SMLR’s stock grew somewhat faster than RSLS’s over the last 12 months.

SMLR's P/E Growth Rating (82) in the Medical Specialties industry is in the same range as RSLS (100). This means that SMLR’s stock grew similarly to RSLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSLSSMLR
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 19 days ago
86%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TARA3.340.22
+6.89%
Protara Therapeutics
REVB0.860.04
+5.45%
Revelation Biosciences Inc
CCAP15.040.30
+2.04%
Crescent Capital BDC
UHS189.390.30
+0.16%
Universal Health Services
ARLP25.750.04
+0.16%
Alliance Resource Partners LP

RSLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RSLS has been loosely correlated with BIAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RSLS jumps, then BIAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSLS
1D Price
Change %
RSLS100%
-1.65%
BIAF - RSLS
49%
Loosely correlated
+1.00%
HSCS - RSLS
35%
Loosely correlated
-0.28%
GMED - RSLS
31%
Poorly correlated
+0.62%
AZTA - RSLS
30%
Poorly correlated
+1.59%
LFWD - RSLS
29%
Poorly correlated
+1.68%
More

SMLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMLR has been loosely correlated with NNOX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SMLR jumps, then NNOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMLR
1D Price
Change %
SMLR100%
+1.04%
NNOX - SMLR
45%
Loosely correlated
+7.80%
RSLS - SMLR
44%
Loosely correlated
-1.65%
RDNT - SMLR
42%
Loosely correlated
+1.00%
CERS - SMLR
39%
Loosely correlated
+9.42%
BFLY - SMLR
38%
Loosely correlated
+5.53%
More